GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed Oct 4, 2018
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2018-10-02$3.79/sh−400,000$1,516,000→ 9,585,848 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established in connection with estate planning.